PHR Dec 2024 12.500 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.8000

0.0000

(0.00%)

As of 01:55PM EDT. Market open.

Loading interactive chart...

Business Wire
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
ALL-REMOTE COMPANY/WILMINGTON, Del., June 10, 2024--Phreesia partners with the National Kidney Foundation and shares new research on early diagnosis and treatment of kidney disease.
Simply Wall St.
Phreesia First Quarter 2025 Earnings: EPS Beats Expectations
Phreesia ( NYSE:PHR ) First Quarter 2025 Results Key Financial Results Revenue: US$101.2m (up 21% from 1Q 2024). Net...
Zacks
Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks
Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.